Showing results (151-160 of 278) with videos related to
Sort By:
Pageof 28
RMD Open|October 29, 2020
Patient's experience of psoriatic arthritis: a conceptual model based on qualitative interviewsAlexis Ogdie, Kaleb Michaud, Miroslawa Nowak, et al.Journal of Clinical Medicine|March 28, 2026
Racial and Ethnic Differences in Labor Duration and Cesarean Indications Among Low-Risk Nulliparous Term Singleton Vertex Births: A Retrospective AnalysisElizabeth Mollard, Huijun Xiao, James Bena, et al.Clinical Rheumatology|April 24, 2023
Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritisMaria A Lopez-Olivo, Kaleb Michaud, Rebecca Schumacher, et al.Rheumatology (Oxford, England)|April 17, 2015
Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritisKaleb Michaud, Vibeke Strand, Nancy A Shadick, et al.BMC Rheumatology|November 29, 2022
Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysisYomei P Shaw, Sara Hustek, Nina Nguyen, et al.Rheumatology and Therapy|May 23, 2022
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDsVardhaman Patel, Zulkarnain Pulungan, Anne Shah, et al.Arthritis Care & Research|October 4, 2016
Utilization of Care Outside the Veterans Affairs Health Care System by US Veterans With Rheumatoid ArthritisPascale Schwab, Harlan Sayles, Debra Bergman, et al.Arthritis Care & Research|February 15, 2020
Defining Pain That Does Not Interfere With Activities Among Rheumatoid Arthritis PatientsYvonne C Lee, Patricia Katz, Amanda Quebe, et al.Arthritis Care & Research|April 24, 2023
Clinical Features Associated With Rate of Fractures in Patients With Systemic Sclerosis: A US Cohort StudyBliss Rogers, Sina Famenini, Jamie Perin, et al.Advances in Therapy|April 21, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic DrugsNoemi Muszbek, Clare Proudfoot, Marie Fournier, et al.Pageof 28